Dr. Abraham Morgentaler

Because there's so many people who give it to men after radical prostatectomies with the parent cure. And it's just, it's an old story that just needs a little bit more time to die maybe. But I'm very hopeful.

Because there's so many people who give it to men after radical prostatectomies with the parent cure. And it's just, it's an old story that just needs a little bit more time to die maybe. But I'm very hopeful.

Because there's so many people who give it to men after radical prostatectomies with the parent cure. And it's just, it's an old story that just needs a little bit more time to die maybe. But I'm very hopeful.

You know, I gave, I was at Tulane and I spoke to the residents there and Wayne Hellstrom is at Tulane and he's been, you know, very highly involved with the testosterone and prostate cancer story. He runs a course at the AUA on testosterone. And the residents have learned from him.

You know, I gave, I was at Tulane and I spoke to the residents there and Wayne Hellstrom is at Tulane and he's been, you know, very highly involved with the testosterone and prostate cancer story. He runs a course at the AUA on testosterone. And the residents have learned from him.

You know, I gave, I was at Tulane and I spoke to the residents there and Wayne Hellstrom is at Tulane and he's been, you know, very highly involved with the testosterone and prostate cancer story. He runs a course at the AUA on testosterone. And the residents have learned from him.

And I was just chatting with them before I started my presentation and said, you guys treat guys in the clinic that you see with testosterone? They say, yes. I say, you treat after radical prostatectomy? They said, yeah. I say, what about guys on active surveillance? You don't do that, do you? They say, oh, yeah. I say, what if it's like Gleason four plus three?

And I was just chatting with them before I started my presentation and said, you guys treat guys in the clinic that you see with testosterone? They say, yes. I say, you treat after radical prostatectomy? They said, yeah. I say, what about guys on active surveillance? You don't do that, do you? They say, oh, yeah. I say, what if it's like Gleason four plus three?

And I was just chatting with them before I started my presentation and said, you guys treat guys in the clinic that you see with testosterone? They say, yes. I say, you treat after radical prostatectomy? They said, yeah. I say, what about guys on active surveillance? You don't do that, do you? They say, oh, yeah. I say, what if it's like Gleason four plus three?

Like they're looking at each other like what's the problem? And the reason is that they now have the experience of treating these men and nothing happens to them. There's a baseline level, of course, of recurrence and progression, but they're not seeing some terrible thing happen. One of the reasons that testosterone was not used for about 50 years after Huggins published his paper

Like they're looking at each other like what's the problem? And the reason is that they now have the experience of treating these men and nothing happens to them. There's a baseline level, of course, of recurrence and progression, but they're not seeing some terrible thing happen. One of the reasons that testosterone was not used for about 50 years after Huggins published his paper

Like they're looking at each other like what's the problem? And the reason is that they now have the experience of treating these men and nothing happens to them. There's a baseline level, of course, of recurrence and progression, but they're not seeing some terrible thing happen. One of the reasons that testosterone was not used for about 50 years after Huggins published his paper

was because everybody was so scared that there were no doctors that had a large group of patients on testosterone that they could say, now hold on a second, I have experience with this. I've got all these patients and they're not getting prostate cancer. Nobody had that experience and so it lived on without a challenge.

was because everybody was so scared that there were no doctors that had a large group of patients on testosterone that they could say, now hold on a second, I have experience with this. I've got all these patients and they're not getting prostate cancer. Nobody had that experience and so it lived on without a challenge.

was because everybody was so scared that there were no doctors that had a large group of patients on testosterone that they could say, now hold on a second, I have experience with this. I've got all these patients and they're not getting prostate cancer. Nobody had that experience and so it lived on without a challenge.

Once doctors have clinical experience with this, it becomes impossible to tell them something that isn't quite true. Like the idea that just a little sniff of testosterone is going to create some trouble makes no sense to somebody if they're already treating and they haven't seen that problem.

Once doctors have clinical experience with this, it becomes impossible to tell them something that isn't quite true. Like the idea that just a little sniff of testosterone is going to create some trouble makes no sense to somebody if they're already treating and they haven't seen that problem.

Once doctors have clinical experience with this, it becomes impossible to tell them something that isn't quite true. Like the idea that just a little sniff of testosterone is going to create some trouble makes no sense to somebody if they're already treating and they haven't seen that problem.

So I think that urologists are already well on their way with the younger generation to recognizing that testosterone really appears to be quite safe in most, maybe not all circumstances, but in most circumstances of men after prostate cancer.

So I think that urologists are already well on their way with the younger generation to recognizing that testosterone really appears to be quite safe in most, maybe not all circumstances, but in most circumstances of men after prostate cancer.